SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Anticipation of Alpha Taus clinical pipeline updates is driving attention, particularly REGAIN glioblastoma data and progress in the pancreatic cancer IMPACT study, alongside other expected trial milestones. Traders are largely bullish on the potential catalysts, though some note the stocks consolidation and uncertainty around what the data will show.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.0036376 USD and is down -1.34 over the last 24 hours. It is currently trading on 374 active market(s) with $6,877,222.43 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

JASMYs price swings have fueled debate over whether recent ecosystem developmentsespecially the AppBank AI/data-services collaboration and JasmyChains use of JASMY for gascan translate into real adoption. Bulls see a stronger utility story and are buying dips, while skeptics point to limited usage, weak performance, and concern that progress has yet to show up in the tokens price.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,505.193803. The last known price of Zebec Network is 0.00179872 USD and is down -2.92 over the last 24 hours. It is currently trading on 133 active market(s) with $9,820,670.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Discussion centers on reported Zebec payroll and payment developments, particularly MoneyGram/Stellar and Germany/AllUnity, alongside Robinhood-related chatter; some traders caution that broader partnership claims remain unconfirmed. Bulls see the integrations as adoption catalysts, while skeptics point to weak price action and want evidence that real usage will drive ZBCN demand.

NRG Energy, Inc. engages in the production, sale, and distribution of energy and energy services. It operates through the following segments: Texas, East, West/Services/Other, Vivint Smart Home, and Corporate Activities. The Texas segment includes all activities related to customer, plant and market operations in Texas, other than Cottonwood. The East segment engages in all activities related to customer, plant and market operations in the East. The West/Services/Other segment is focused on all activities related to customer, plant and market operations in the West and Canada, and activities related to the Cottonwood facility and other investments. The Vivint Smart Home segment is a smart home platform that provides customers with technology, products and services to create a smarter, greener, safer home. The company was founded in 1989 and is headquartered in Houston, TX.

NRG Energy Inc.

NRG is rallying alongside other power producers after PJM accelerated its timeline for connecting data centers to the grid, reinforcing the communitys AI-driven electricity-demand thesis. Traders are debating whether the move signals a sustained recovery or a volatile bounce, with concerns about uncertain data-center growth and power-market pressures still present.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Attention centers on encouraging early zugo-cel results in autoimmune diseases, with traders highlighting responses in systemic sclerosis and myositis and the therapys reported tolerability. Bulls view the data as support for an off-the-shelf CD19 CAR-T approach, while others caution that the patient groups are small and longer follow-up is needed to assess durability and safety.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Concern that AI consulting pilots may not convert into funded enterprise programs is driving discussion, with traders warning that disputed returns and client pauses could leave Accenture consultants underutilized and pressure billable revenue. Others see AI implementation work as an opportunity, while technical traders debate whether the stocks sharp rebound is due for a pullback.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnbs stronger-than-expected quarterly results, raised revenue outlook and new share-buyback authorization are driving a sharp rally. Bulls are celebrating renewed growth and cash returns, while skeptics question whether the gains can hold and point to consumer and travel-demand risks.

Vanguard World Fund - Vanguard Information Technology ETF

Vanguard Information Technology ETF

VGT is drawing attention amid a pullback in technology shares, with traders debating whether weakness tied to broader market and macro uncertainty is a buying opportunity or the start of a deeper correction. Many are adding or dollar-cost averaging for long-term tech and AI exposure, while others are waiting for further declines; some also point to call-heavy options activity as a sign of bets on a rebound.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Speculation that fighting with Iran could resume is dominating discussion, with traders concerned that a resulting oil and jet-fuel spike would pressure Air Canadas costs and share price. Some point to the share-buyback program and lower oil prices as potential support, but the conversation is largely bearish and the conflict scenario remains unconfirmed.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertexs Q3 report drew mixed reactions: traders noted revenue growth and a slightly raised full-year outlook, but some focused on the adjusted-EPS miss and questioned the valuation. The larger recurring catalyst is the Nov. 30 FDA decision on povetacicept for IgA nephropathy; bullish traders point to the RAINIER results, while approval and commercial prospects remain uncertain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

https://www.marketbeat.com/earnings/reports/2026-11-6-essent-group-ltd-stock/

$ESNT Essent Group Earnings Transcript

Essent Group reported Q3 2026 earnings of $1.82 per share on November 6, 2026, missing the $1.85 consensus estimate, on revenue of $374.18 million. See the results and press release for ESNT at MarketBeat.